Physician profile
Hom-Lay Wang
NPI 1316061757
$396,484.14
in general payments reported to CMS, 2019-2025
11 companies · $26K in 2025
The $26K reported for 2025 was more than what 99% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105K · 2020: $25K · 2021: $24K · 2022: $108K · 2023: $54K · 2024: $55K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $103K · Travel and Lodging: $21K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $103,000.00 |
| Travel and Lodging | $20,719.92 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,000.00 |
| Food and Beverage | $625.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohorizons Implant Systems INC. | $240,925.18 | 2019-2025 | Biohorizons, Biohorizons Dental Implants |
| J. Morita USA, INC. | $65,345.13 | 2019-2023 | |
| Osteogenics Biomedical INC. | $44,000.00 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $22,413.48 | 2019-2022 | |
| Meisinger USA, LLC | $11,842.83 | 2019 | |
| Envista Holdings Corporation | $11,386.04 | 2024 | |
| Straumann USA LLC | $227.69 | 2024-2025 | |
| Zimvie INC. | $158.53 | 2022-2025 | |
| Geistlich Pharma, North America, INC. | $100.00 | 2019 | |
| Gc America INC. | $74.14 | 2025 | Cytrans Granules |
| Hu-Friedy Mfg. Co., LLC | $11.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hom-Lay Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.